Eton Pharmaceuticals Liabilities 2024

Eton Pharmaceuticals Aktienanalyse

What does Eton Pharmaceuticals do?

The company Eton Pharmaceuticals Inc is an innovative company that specializes in the development of high-quality and reliable medications. The company was founded in 2017 in Deer Park, Illinois, and has since become a leading company in the pharmaceutical industry. Eton Pharmaceuticals Inc's business model is closely related to the development of new medications. The company specializes in the development of so-called "gel-coated" medications, which have better efficacy and tolerability than conventional medications. The company uses innovative and patented technologies to overcome the current limitations of medications and provide customers with the best possible treatment. Eton Pharmaceuticals Inc has different divisions for the development of medications. One of the most important divisions is oncology, where medications for tumor treatment are developed. The company relies on innovative approaches to discover new active substances and improve the treatment of cancer patients. In addition, the company has extensive experience in the production of antibiotics. Eton Pharmaceuticals Inc has developed its own products tailored to the needs of patients, promising fast and effective effects. The company has also developed special medications for the treatment of cardiovascular diseases, aiming to provide patients with a better quality of life. One of the products offered by Eton Pharmaceuticals Inc is the medication "BML-190". This medication is an anti-inflammatory drug used for pain and inflammation. Its special feature is its high effectiveness with minimal side effects, which often occur with other medications. Another product of Eton Pharmaceuticals Inc is the medication "DS-300", used for certain eye diseases. The medication contains an active substance that acts on the eyes and allows for quick healing. Thanks to the innovative technology used in its development, this medication is well tolerated and has minimal side effects. Overall, Eton Pharmaceuticals Inc is an innovative company specializing in the development of high-quality medications. With its business model and expertise in various areas of the pharmaceutical industry, the company is well equipped to continue making significant contributions to healthcare. Eton Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Eton Pharmaceuticals's Liabilities

Eton Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Eton Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Eton Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Eton Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Eton Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Eton Pharmaceuticals stock

What is the level of liabilities of Eton Pharmaceuticals this year?

Eton Pharmaceuticals has a debt balance of 16.26 M USD this year.

What were the liabilities of Eton Pharmaceuticals compared to the previous year?

The liabilities of Eton Pharmaceuticals have increased by 36.09% increased compared to the previous year.

What are the consequences of high debt for investors of Eton Pharmaceuticals?

High liabilities can pose a risk for investors of Eton Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Eton Pharmaceuticals?

Low liabilities mean that Eton Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Eton Pharmaceuticals affect the company?

An increase in liabilities of Eton Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Eton Pharmaceuticals affect the company?

A decrease in the liabilities of Eton Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Eton Pharmaceuticals?

Some factors that can influence the liabilities of Eton Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Eton Pharmaceuticals so important for investors?

The liabilities of Eton Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Eton Pharmaceuticals take to modify the liabilities?

To change its liabilities, Eton Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Eton Pharmaceuticals pay?

Over the past 12 months, Eton Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eton Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Eton Pharmaceuticals?

The current dividend yield of Eton Pharmaceuticals is .

When does Eton Pharmaceuticals pay dividends?

Eton Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eton Pharmaceuticals?

Eton Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Eton Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eton Pharmaceuticals located?

Eton Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eton Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eton Pharmaceuticals from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did Eton Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of Eton Pharmaceuticals in the year 2023?

In the year 2023, Eton Pharmaceuticals distributed 0 USD as dividends.

In which currency does Eton Pharmaceuticals pay out the dividend?

The dividends of Eton Pharmaceuticals are distributed in USD.